Visalytics
Visalytics
approved EB-2 (NIW)

Senior Scientist

Cell And Molecular Biology · India · 2025-09-25

Processing Time
51 days
Decision Date
2025-09-25
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop, engineer, and refine scalable stem-cell and progenitor-cell-derived organoid systems to revolutionize human organ modeling. Her work focuses on creating miniature, lab-grown structures that replicate complex human tissues for use in drug screening, disease modeling, and patient-specific regenerative therapies.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses the shortage of transplantable organs and limitations in drug testing, which are of immense concern to the American healthcare system.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 124 citations and funding from major federal agencies like the NIH and NSF demonstrates her influence and capability in the field.

3 Waiver Benefit Met

On balance, the U.S. benefits from waiving the labor certification due to the petitioner's unique contributions to regenerative medicine and healthcare innovation.

Why This Petition Was Approved

The petition was approved based on the petitioner's authorship of five peer-reviewed journal articles, five abstracts, and one preprint, which accumulated 124 citations. Her work's significance was further validated by funding from the National Science Foundation (NSF) and the National Institutes of Health (NIH), satisfying the Dhanasar prongs for merit and national importance.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Conference Presentations
Grants
Reference Letters Dependent
Government Alignment

Similar Cases

Researcher

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Maryland 89 days 2022-05-07
The petitioner proposes to continue his research in advancing stem cell and tissue engineering science to develop artificial blood and organs for practical applications in clinical medicine. His work focuses on developing three-dimensional scaffolds for generating liver tissue and gene delivery platforms for directing stem cell differentiation.
View Case

Scientist

Biotechnology · India

WeGreened EB-2 (NIW) rfe approved
Massachusetts 313 days 2025-02-03
The petitioner proposes to develop state-of-the-art cell and gene therapies to establish cures for debilitating diseases such as cancer and traumatic brain injury. The work focuses on enhancing therapeutic strategies through novel backpack technologies for cell engineering and advanced RNA-based therapeutic platforms.
View Case

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
103 days 2024-02-02
The petitioner proposes to lead oncology projects focusing on organoid platforms and high-throughput screening to identify new immuno-oncology drug candidates. Her work utilizes three-dimensional organoid models and epigenetic profiling to investigate mechanisms of stemness in cancer stem cells and the role of necroptosis in disease progression. The goal is to identify therapeutic targets that curb tumor growth and enhance immune responses for personalized cancer medicine.
View Case

Assistant Professor

Biotechnology

WeGreened EB-2 (NIW) approved
Washington 57 days 2025-04-14
The petitioner proposes to advance gene and base editing techniques within complex three-dimensional (3D) organoid models to accurately model genetic diseases. This work involves discovering new gene-based therapies, engineering functional tissues, and enhancing capabilities in organ regeneration and transplantation. The endeavor aims to improve the effectiveness and affordability of treating genetic conditions in the U.S.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-09-25.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 51 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,814
Success Rate 53.6%
Sustained 2,046
Dismissed 1,672

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist